<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>COPD + Smoking Cessation Articles from ACP JournalWise And McMaster PLUS</title><link>http://journalwise.acponline.org</link><description>Top 5 Highest Rated Articles For COPD + Smoking Cessation In The Last 30 Days</description><language>en-us</language><pubDate>6/20/2013 12:00:00 AM</pubDate><copyright>Copyright (C) HIRU - Mcmaster University 2013</copyright><generator>http://PLUS.mcmaster.ca RSS Generator</generator><item><title>Cardiovascular Safety of Inhaled Long-Acting Bronchodilators in Individuals With  Chronic Obstructive Pulmonary Disease.</title><link>http://journalwise.acponline.org/RssArticle.aspx?COPDID=C2D5E4DBD6DFC6DBD8A6989E96A09A</link><description>JAMA Intern Med. 2013 May 20:1-9. doi: 10.1001/jamainternmed.2013.1016.&lt;br&gt;IMPORTANCE Chronic obstructive pulmonary disease (COPD) is a common and deadly disease. Long-acting inhaled beta-agonists and anticholinergics, first-line medications for COPD, have been associated with increased risk of cardiovascular  outcomes. When choosing between the medications, patients and physicians would benefit from knowing which has the least risk. OBJECTIVE To assess the association of these classes of medications with the risk of hospitalizations and emergency department visits for...</description><guid isPermaLink="false">52176</guid></item><item><title>Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.</title><link>http://journalwise.acponline.org/RssArticle.aspx?COPDID=C2D5E4DBD6DFC6DBD8A6989E9AA29D</link><description>Cochrane Database Syst Rev. 2013 May 31;5:CD007891. doi: 10.1002/14651858.CD007891.pub3.&lt;br&gt;BACKGROUND: Combination therapy (inhaled corticosteroids and long-acting beta2-agonists) and tiotropium are both used in the treatment of chronic obstructive pulmonary disease (COPD). There is uncertainty about the relative benefits and harms of these treatments. OBJECTIVES: To compare the relative effects of inhaled combination therapy and tiotropium on markers of exacerbations, symptoms, quality of life, lung function, pneumonia and serious adverse events in patients with chronic obstructive p...</description><guid isPermaLink="false">52599</guid></item><item><title>Implementation of self management support for long term conditions in routine primary care settings: cluster randomised controlled trial.</title><link>http://journalwise.acponline.org/RssArticle.aspx?COPDID=C2D5E4DBD6DFC6DBD8A6989E959F94</link><description>BMJ. 2013 May 13;346:f2882. doi: 10.1136/bmj.f2882.&lt;br&gt;OBJECTIVE: To determine the effectiveness of an intervention to enhance self management support for patients with chronic conditions in UK primary care. DESIGN: Pragmatic, two arm, cluster randomised controlled trial. SETTING: General practices, serving a population in northwest England with high levels of deprivation. PARTICIPANTS: 5599 patients with a diagnosis of diabetes (n=2546), chronic obstructive pulmonary disease (n=1634), and irritable bowel syndrome (n=1419) from 43 practices (19 inte...</description><guid isPermaLink="false">52060</guid></item></channel></rss>